Status:
COMPLETED
The Role of Visfatin in Obesity and Periodontal Disease
Lead Sponsor:
Gazi University
Conditions:
Obesity
Periodontitis
Eligibility:
All Genders
20-68 years
Brief Summary
Visfatin is an adipokine that plays an important role in immune functions as a growth factor, enzyme, and proinflammatory mediator. The investigators aimed to determine the levels of visfatin, interle...
Detailed Description
Overweightness and obesity are defined as the accumulation of fat in body tissues that might impair overall health. Adults are considered overweight if their body mass index (BMI, calculated as weight...
Eligibility Criteria
Inclusion
- having \> 22 natural teeth
- no systemic diseases
- having good cooperation
- having BMI \> 30
- waist circumference \> 88 cm for females for obese patients
- waist circumference \> 102 cm for males for obese patients
- age \> 20 years
Exclusion
- presence of localized chronic periodontitis
- received periodontal therapy/surgery in the previous 6 months
- pregnancy
- use of any hormone therapy
- history of antibiotic or anti-inflammatory drugs therapy within the previous 6 months
- current and former smoker
- lactation
- presence of aggressive periodontitis
- presence of periapical pathologies
Key Trial Info
Start Date :
October 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03470987
Start Date
October 1 2013
End Date
September 1 2014
Last Update
March 21 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gazi University Faculty of Dentistry
Ankara, Turkey (Türkiye)